Bulbitech

One neuro-ocular diagnostic device that supports the neurological part of the eye examination

The problems we solve

  • Absence of a dedicated neuro-ocular diagnostic device during the eye examination
  • Manually or not performing the important neurological part of the eye examination
  • Subjective clinical interpretation of neuro-ocular tests results
  • Single test units for every examination
  • Manually inserting test results
  • Inefficient clinical workflow
  • Not able to bill the neurological part of the eye examination

Our purpose

Our goal is to provide neuro-ophthalmologists, ophthalmologists and optometrists with a neuro-ocular diagnostic support device for the early detection of neuro-ocular disorders, based on eye tracking technology. Our BulbiCAM offers the user multiple neuro-ocular examinations of which the outcome can be assessed in our BulbiHUB software, making it possible to quickly and objectively add the neurological part of the eye examination to your diagnostic workflow. In addition results can be shared amongst clinicians through our telemedicine functionality, facilitating the patient to undergo the examination at a physical location while the neuro-ophthalmologist is working remotely. Ultimately our BulbiCAM requires the patient to do the work, can be operated by anyone and generates objective clinical results needed to fully assess the patient’s neuro-ocular condition.

Early detection of neuro-ocular disorder with a dedicated neuro-ocular diagnostic device that reduces patient chair time

Decentralizing access to neuro-ocular examinations adding remote accessibility to patient's test results for neuro-ophthalmic specialists

Supporting already understaffed eye care professionals to face an increase demand of eye care by providing them a neuro-ocular diagnostic support device in which the patient does the work and can be operated by anyone

Generating objective clinical results, reducing manually performed neuro-ocular examinations

BulbiCAM

One neuro-ocular diagnostic device offering multiple examinations

One neuro-ocular diagnostic device offering multiple examinations
  • 400 FPS eyetracking
  • Two screen system allows to present stimuli to left and right eye
  • Accurate timing synchronization
  • Calibration free eye tracking test setups
  • Individual compensation of refractive errors and head shape
  • Patients can be tested standing, sitting or laying
  • No table space required
  • Expected date of CE-certificate: Q4-2020

More information is coming soon. To stay updated please register your interest and subscribe to our newsletter

Our solution

BulbiHUB software

Software enables users to assess clinical outcome of all eye examination tests conducted with our BulbiCAM. Furthermore it is able to process clinical outcome from eye examinations conducted with third party ophthalmic devices resulting in one unique clinical dashboard overview of clinical test results

Telemedicine

Data can be shared, tele ophthalmology consultations with patients are possible and third-party devices can be integrated, resulting in a clinical workflow that can continue remotely during pandemic outbreaks

AI [Artificial Intelligence]

Algorithms can be developed to detect early stage neuro- ocular dysfunctions and analyze our collected “big data” in order to become the first company that generates AI analysis on eye tracking data

Current Tests

Visual Field test

Visual Field test

Based on eye movement perimetry our 26-point visual field test screens the patient's visual field in 90 seconds per eye. Measuring the saccadic reaction time, an index for detection of glaucomatous visual field defects, our visual field test quantifies the reaction time towards a peripheral target and detects blind spots

Pupil test

Pupil test

Our pupil test, in four sequences of alternating black and white light patters, simultaneously quantifies both direct and consensual pupillary light reflex in order to detect Relative Afferent Pupil Defect (RAPD)

Ptosis test

Ptosis test

Ptosis is a drooping or falling of the upper eyelid and can be one of the first signs of stroke, brain tumour, cancer, neurological disorders or damage to the nerves or muscles supporting the eyelid

Saccade test

Saccade test

Performed during the visual field test our saccade test measures the peak velocity of horizontal, vertical and oblique saccades to early detect potential neurological diseases, such as Parkinson's disease, dementia or Huntington's disease

Upcoming Tests

Acuity test

Acuity test

Eye tracking based acuity testing is objective, doesn’t require operational assistance, and takes just 60 seconds

Nystagmus test

Nystagmus test

Nystagmus is a “wobbling eye” due to an involuntary eye movement. Nystagmus prevalence is estimated to be 24 persons in a 10.000 population. Currently there is no objective quantification of nystagmus

Strabismus test

Strabismus test

Eye deviations are manually assessed, and subjectively interpreted. BulbiCAM will quantify the results of horizontal and vertical eye deviations

Cover Test

Cover test

Automated eye deviation tested using eye tracking technology. Patient stimulus allows the measurement of eye positions under single and alternating cover-uncover test

Vergence Test

Vergence test

Automated smooth vergence assessment, using virtually 3D stimulus, gives quantified data for near point of convergence and recovery including near pupil reflex

Benefits of our technology

  • Early detects neuro-ocular disorders
  • Reduces treatment costs
  • Reduces patient chair time
  • Objectives clinical outcome of neuro-ocular examinations
  • Decentralizes access to neuro-ocular testing
  • Adds neurological part of the eye examination to your service
  • Optimizes profit per neuro-ocular examination

Our company

Our Timeline

2015
Funding from public funds and private investors for technology development
2016
Technical R&D development on eye tracking
2017
Company & software CE-marks based on QMS
2018
Funding from public funds and private investors to complete smaller prototype
2019
Froze BulbiCAM for clinical trials Finalist in the DNB Healthcare prize

Our team

Board

ODD HJELMELAND

ODD HJELMELAND

Executive Chairman
TOR ULLEBERG

TOR ULLEBERG

Executive Board Member
KENT THOMAS HÅGENSTAD RANUM

KENT THOMAS HÅGENSTAD RANUM

Executive Board Member
HARALD FREDRIK ULLTVEIT-MOE

HARALD FREDRIK ULLTVEIT-MOE

Ophthalmologist

Management team

BÅRD DALHØI

BÅRD DALHØI

CSO
bard@bulbitech.com
HANS-PETER KURZ

HANS-PETER KURZ

CTO
hape@bulbitech.com
DENNIS HENS

DENNIS HENS

CEO
dennis@bulbitech.com
BJØRN ANDRÉ HELLAND-HANSEN

BJØRN ANDRÉ HELLAND-HANSEN

CMO
bjorn@bulbitech.com
MARTIN LEIN STAVELI

MARTIN LEIN STAVELI

CFO
martin@bulbitech.com

Clinical Advisory Board

KLAUS A. SJØHAUG

KLAUS A. SJØHAUG

Optometrist/Doctor of Optometry

JOHAN PEL

JOHAN PEL

Associate Professor Neuroscience

HANS VAN DER STEEN

HANS VAN DER STEEN

Professor Neuroscience

STIG LARSEN

STIG LARSEN

Professor Controlled Clinical Research Methodology and Statistics

Partners

Optiikka Juurinen Logo
Lameris
Eggs
Norway Innovation
University of South-Eastern Norway
Rodenstock logo
Erasmus MC
Norway Health Tech
MHJ

Please subscribe to our newsletters